EFPIA：2026年评估欧洲作为生命科学产业基地的竞争力叙述性报告（英文版）

Once a beacon of scientific excellence and a modern powerhouse in pharmaceuticals, Europe now risks further falling behind global peers, including China and the United States, which are outpacing Europe in attracting pharmaceutical investment, initiating more clinical trials and originating a greater share of novel pharmaceutical innovations. Competitiveness has become a political and policy priority across sectors in Europe. The life sciences industry is one of Europe’s most important strate